Jefferies relève l’objectif de cours de Corvus Pharmaceuticals à 42€ suite à des données solides sur la maladie d’Alzheimer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback